Allspring Global Investments Holdings, LLC
Position in PBYI — Puma Biotechnology, Inc.
CIK 1890906
CHARLOTTE, NC
Position in PBYI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$109,051
+$107,351 QoQ
Shares Held
17,066
+2458.6% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allspring Global Investments Holdings, LLC holds $699,540,915 across 64 Biotechnology names. PBYI ranks #59 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
175,311 | $128,020,857 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,793 | $93,236,848 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,707,715 | $73,243,895 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
889,356 | $66,043,575 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
123,760 | $55,263,790 | |
| 6 | INSM |
INSMED Inc
|
282,734 | $46,232,662 | |
| 7 | ASND |
Ascendis Pharma A/S
|
184,224 | $42,137,554 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,497 | $40,561,281 |
All Filings in PBYI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $109,051 | 17,066 | Shares | Defined | 2026-05-05 | |
| 2024-09-30 | $1,700 | 667 | Shares | Defined | 2024-10-18 | |
| 2022-03-31 | $711,936 | 247,200 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $751,488 | 247,200 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||